Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Clinical trial NCT07162038 · RECRUITING

Trial details

NCT number: NCT07162038
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies Hematologic Neoplasms

Start date: 2025-11-14
Primary completion: 2030-11-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.